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Exogenous application of gangliosides to cells affects many cellular functions. We asked whether
these effects could be attributed to the influence of gangliosides on the properties of sphingolipid–
cholesterol microdomains on the plasma membrane, also termed rafts. The latter are envisaged as
lateral assemblies of sphingolipids (including gangliosides), cholesterol, and a specific set of
proteins. Rafts have been implicated in processes such as membrane trafficking, signal transduc-
tion, and cell adhesion. Recently, using a chemical cross-linking approach with Madin-Darby
canine kidney (MDCK) cells permanently expressing a GPI-anchored form of growth hormone
decay accelerating factor (GH-DAF) as a model system, we could show that GPI-anchored
proteins are clustered in rafts in living cells. Moreover, this clustering was dependent on the level
of cholesterol in the cell. Here we show that incubation of MDCK cells with gangliosides abolished
subsequent chemical cross-linking of GH-DAF. Furthermore, insertion of gangliosides into the
plasma membrane of MDCK GH-DAF cells renders GH-DAF soluble when subjected to extraction
with Triton X-114 at 4°C. Our data suggest that exogenous application of gangliosides displaces
GPI-anchored proteins from sphingolipid–cholesterol microdomains in living cells.
INTRODUCTION
Exogenously added gangliosides affect various biological
systems. They lead to increased cell adhesiveness, inhibit
cell growth, promote cell differentiation, and induce neuri-
togenesis (Hakomori and Igarashi, 1995). Furthermore, gan-
glioside treatment is neuroprotective in many in vivo and in
vitro models of neuroinjury (Hadjiconstantinou and Neff,
1998). For example, experimental Parkinsonism is partially
reversed by ganglioside treatment. Both, GM1 and a lyso-
derivative of GM1 given after cortical thrombosis reduce
infarct size and associate cognitive deficits (Schneider et al.,
1992; Kharlamov et al., 1994). Several clinical trials have
supported application of gangliosides for treating neurolog-
ical disease (Geisler et al., 1991; Lenzi et al., 1994). Despite the
large number of observed effects, the molecular mechanisms
involved in ganglioside action are poorly understood. There
is evidence that application of gangliosides alters many
phosphorylation systems (Hakomori and Igarashi, 1995).
Signaling pathways initiated by receptor-associated tyrosine
kinases or mediated by protein kinase C, MAP kinase, and
other kinases are affected by gangliosides (Hakomori and
Igarashi, 1995).
The wide spectrum of biological effects exerted by gan-
gliosides could be explained by interaction of gangliosides
with signaling molecules or by influence of the overall struc-
ture of plasma membrane, in particular on the formation of
cholesterol–sphingolipid rafts. The latter are envisaged as
lateral assemblies of specific lipids and proteins in cellular
membranes proposed to function in processes such as mem-
brane transport, signal transduction, and cell adhesion (Si-
mons and Ikonen, 1997). They are thought to be small and
highly dynamic structures, which explains the difficulties in
resolving them using conventional microscopical tech-
niques. Attractive forces between sphingolipids and choles-
terol have been postulated to be responsible for the forma-
tion of the lateral lipid assembly. Several proteins have been
suggested to associate with rafts, including GPI-anchored
proteins (GPI-APs), Src-family kinases, influenza virus hem-
agglutinin (HA), and caveolin-1 (Simons and Ikonen, 1997).
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An interesting feature of raft-associated proteins is that most
of them carry posttranslational lipid modifications: GPI-
anchored proteins are anchored in the cell membrane via a
lipid moiety, whereas Src-family kinases, NO synthase, HA,
and caveolin are acylated. The lipophilic character of raft
proteins may explain their common behavior of poor solu-
bility in cold nonionic detergents such as Triton X-100 (Si-
mons and Ikonen, 1997). Triton insoluble complexes have
been operationally defined as rafts that are specifically en-
riched in certain lipids (e.g., sphingolipids, including gan-
gliosides and cholesterol), whereas other lipids (e.g., glyc-
erophospholipids) are selectively depleted from the extracts
(Brown and Rose, 1992; Fiedler et al., 1993); however, the
existence of rafts in living cells remained elusive. Recently it
was possible to demonstrate the existence of cholesterol-
dependent microdomains of GPI-anchored proteins in living
cells by a chemical cross-linking approach (Friedrichson and
Kurzchalia, 1998) and by a novel fluorescent energy-transfer
method (Varma and Mayor, 1998). In this article we used our
cross-linking approach to investigate how the exogenous
application of gangliosides affects rafts in living cells.
MATERIALS AND METHODS
Cell Culture
Madin-Darby canine kidney (MDCK) growth hormone decay accel-
erating factor (GH-DAF) cells were maintained at 37°C in 5% CO2 in
DMEM supplemented with 10% FCS and antibiotics. Chinese ham-
ster ovary (CHO) GPI-anchored folate receptor (FR-GPI) cells were
grown in folate-free Ham’s F-12 medium containing 5% FCS, hy-
gromycin (100 mg/ml), penicillin (100 U/ml), and streptomycin (100
mg/ml). Experiments were performed on confluent or subconfluent
cells grown in plastic dishes or on coverslips for immunofluores-
cence labeling.
Insertion of Lipids, Cholesterol Depletion, and
Octylglucoside Treatment of Cells
Stock solutions of bovine brain gangliosides (bbGs) or GM1 (1–10 mM)
were prepared in PBS. Cells were loaded with 10–100 mM gangliosides
in DMEM for 1 h at 37°C (Masserini et al., 1990; Saqr et al., 1993). To
remove excess lipid, cells were washed extensively with PBS contain-
ing 2 mg/ml defatted BSA (PBS/BSA). A 0.5% ethanolic stock solution
of 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexade-
canoyl-sn-glycero-3-phosphocholine (NBD-C6-HPC) was injected un-
der vigorous vortexing into PBS to yield a 1-mM solution. Insertion of
NBD-C6-HPC into membranes was performed with 10–100 mM NBD-
C6-HPC for 1 h at 8°C. To deplete MDCK GH-DAF cells of cholesterol,
they were incubated for 1 h at 37°C with 10 mM methyl-b-cyclodextrin
(CD). For octylglucoside treatment, MDCK GH-DAF cells were incu-
bated for 1 h at 37°C with various concentrations of octylglucoside
dissolved in DMEM.
Quantification of Ganglioside Association
GM1 was extracted, purified (Tettamanti et al., 1973), and radiola-
beled at C-3 of the long-chain base moiety (Sonnino et al., 1984). The
homogeneity of the radioactive compound 3H-GM1 was .99%, and
its specific radioactivity was 1.31 Ci/mmol. Cells were incubated for
1 h in DMEM containing 1 mCi/ml tritiated GM1 (final ganglioside
concentration 100 mM), washed with PBS/BSA, and subsequently
incubated for 0–45 min with PBS/BSA at 37°C. Cells were then
treated for 5 min at 37°C with 1 ml PBS containing 0.1% trypsin. Cell
lysates were analyzed for radioactive ganglioside content with a
liquid scintillation counter (Beckmann Instruments, Fullerton, CA).
Protein was determined using a Protein Assay Reagent (BCA;
Pierce, Rockford, IL).
Detergent Extraction
Cells were washed with cold PBS and extracted with 1 ml TX-114
lysis buffer at 4°C for 30 min. Cells were scraped, and samples were
centrifuged for 30 min at 15,000 3 g at 4°C. The supernatant (soluble
fraction) was removed, and the pellet (insoluble fraction) was re-
suspended in 1 ml lysis buffer. Soluble and insoluble fractions were
precipitated with 10% TCA for 1 h on ice and centrifuged for 15 min
at 15,000 3 g at 4°C. The pellets were washed with acetone (220°C)
and subjected to SDS-PAGE and Western blotting.
Cross-linking, Electrophoresis, and Western Blotting
The cross-linking protocol has been described recently (Friedrichson
and Kurzchalia, 1998). Briefly, cells were washed twice with cold
PBS. Cross-linking was performed with 0.5 mM bis(sulfosuccinimi-
dyl)suberate (BS3) for 45 min at 4°C. Unreacted cross-linker was
quenched with 50 mM glycine for 15 min at 4°C. Cells were lysed for
20 min at 4°C and 10 min at 37°C in TX-114 lysis buffer (150 mM
NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% Triton X-114, and
protease inhibitors). Lysates were briefly chilled on ice and cleared
by a 15 min centrifugation at 15,000 3 g. Supernatants were sub-
jected to temperature-induced phase separation for 5 min at 37°C.
Aqueous and detergent-enriched phases were separated by a 3-min
centrifugation at 13,000 rpm at room temperature (RT). Aqueous
phases were discarded, and 0.9 ml TX-114 wash buffer (150 mM
NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.06% Triton X-114,
and protease inhibitors) was added to detergent phases. After a 15
min centrifugation at 15,000 3 g at 4°C, the samples were subjected
to another round of phase separation. Finally, detergent phases
were precipitated with cold acetone (220°C) and boiled at 95°C for
5 min in Laemmli sample buffer. Proteins were resolved on a 5–15%
SDS-PAGE and transferred to nitrocellulose. Polyclonal antibodies
against GH and FR followed by the respective secondary antibodies
and ECL were used to detect GH-DAF and FR-GPI. Immunoreactive
bands were quantified by densitometric scanning of films or lumi-
nescent image analyzer LAS-1000 (Fujifilm, Straubenhardt, Germa-
ny). Data for each condition were averaged, and the variability was
expressed as SD. Experiments were performed three to six times.
For some gels, corresponding x-ray films were scanned using Pho-
toshop software, and optical density of immunoreactive bands was
determined and plotted using MacBas (version 2.0).
Immunofluorescence
Cells grown on coverslips were washed three times with PBS and
fixed for 6 min with 3.7% paraformaldehyde in PBS at 8°C and for
10 min with methanol at 220°C. Subsequently, the cells were incu-
bated for 30 min at RT with anti-GH antibody in PBS, followed by
incubation with Cy3-conjugated anti-sheep IgG for 30 min at RT.
Each of the above incubations was followed by three washes with
PBS. The coverslips were mounted with mowiol, and images were
captured with a high-resolution digital camera C 4742–95
(Hamamatsu Photonics K.K., Hamamatsu, Japan), and digital de-
convolution was performed using the Openlab (version 1.7.7) digital
confocal routine (Coventry, United Kingdom).
For antibody-induced cross-linking experiments of GH-DAF, an-
ti-GH antibody and Cy3-conjugated anti-sheep IgG were diluted in
DMEM. Cells were incubated for 20 min at 37°C with anti-GH
antibody, washed with DMEM, and incubated for 20 min at 37°C
with Cy3-conjugated anti-sheep IgG. Cells were fixed and mounted
as described above.
Viral Infection and Antibody-induced Patching
For infection with HA influenza virus, virus was diluted in infection
medium (MEM, 50 mM HEPES, pH 7.3, penicillin [100 U/ml]/
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streptomycin [100 mg/ml], 0.2% BSA), and virus adsorption was
performed for 1 h. Infection was allowed to continue for a further
2.5 h; 100 mM GM1 diluted in DMEM was added to some cells
during the last hour. For antibody-induced patching of HA and
GH-DAF, cells were incubated with polyclonal anti-GH antibody
and monoclonal anti-HA-PR8 (H17L10) diluted 1:3000 and 1:50 in
DMEM, respectively. Incubation was performed for 1 h at 4°C. After
they were washed briefly with PBS/0.2%BSA, cells were incubated
with the respective FITC and Cy-3–coupled secondary antibodies
for 1 h at 4°C. Cells were fixed and mounted, and images were taken
as described above. For quantification, 60 randomly selected cells
out of two different experiments were stored as digital images. Cells
were divided into three different categories according to the degree
of overlap between patches: 1) coclustering (.70% overlap); 2)
partial coclustering; and 3) random distribution.
RESULTS
Inhibition of Cross-linking of GPI-anchored
Proteins by Exogenous Administration of
Gangliosides
Our model for analysis of the organization of GPI-anchored
proteins on the surface is a MDCK cell line permanently
expressing GH fused to the GPI-anchor of DAF (GH-DAF)
(Friedrichson and Kurzchalia, 1998). When MDCK GH-DAF
cells were subjected to chemical cross-linking with BS3, a
prominent 46-kDa band (dimer) and a smear starting from
60 kDa reaching up to 300 kDa were detected by Western
blotting (Figure 1A). To investigate the influence of ganglio-
sides on rafts, MDCK GH-DAF cells were loaded with vary-
ing concentrations of GM1 for 1 h in serum-free medium at
37°C and subjected to cross-linking with BS3. As seen in
Figure 1A, treatment of MDCK GH-DAF cells with GM1
reduced significantly the amount of cross-linked GH-DAF.
Quantification of immunoreactive bands revealed that 73 6
6% of GH-DAF formed oligomers in untreated cells,
whereas 65 6 7, 57 6 7, and 49 6 7% of GH-DAF were found
in cross-linked species in cells treated with 10, 50, and 100
mM GM1, respectively. Incubation of cells with bbGs also
efficiently inhibited the formation of GH-DAF oligomeres
(Figure 1B [for 100 mM bbG cross-linking efficiency was 51 6
5% compared with 73 6 6% in untreated cells]). To deter-
mine whether the ability of gangliosides to resolve GPI-AP–
containing rafts is independent of the cell type, CHO cells
permanently expressing FR-GPI were subjected to the same
treatments. Cross-linking of CHO FR-GPI cells with BS3 led
to the appearance of cross-linked products of FR-GPI (cross-
linking efficiency 28 6 3%). When CHO FR-GPI cells were
loaded with 100 mM GM1 or 100 mM bbG before cross-
Figure 1. Gangliosides inhibit cross-linking of GH-DAF in MDCK
cells. MDCK GH-DAF cells were incubated with 0, 10, 50, and 100
mM GM1 (A) or with 10, 50, and 100 mM bbG (B) for 1 h at 37°C.
Cells were subsequently subjected to cross-linking with BS3. Pro-
teins were resolved on 5–15% SDS-PAGE and after Western blotting
were detected with anti-GH antibody followed by ECL. Western
blots were scanned, and the intensity of immunoreactive signal is
given as relative optical density (ROD) for 0 mM GM1 (A, bottom
curve), 0 mM bbG (B, bottom curve), 100 mM GM1 (A, top curve),
and 100 mM bbG (B, top curve).
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linking, the cross-linking efficiency was reduced to 2.7 6 2.5
and 3.3 6 2%, respectively (Figure 2).
To quantify the amount of GM1 that is incorporated into
the plasma membrane, we incubated MDCK GH-DAF cells
with 1 mCi/ml tritiated GM1 (final ganglioside concentration
100 mM) for 1 h. Only ;0.7% of exogenously added gangli-
oside associated with cells. Approximately 35% of total as-
sociated GM1 could be removed by incubating cells with
BSA solution (Figure 3A). By subsequent treatment of cells
with trypsin, two pools of associated GM1 could be detected.
Approximately 30% of the remaining GM1 was released by
trypsin treatment (trypsin-labile pool), and 70% was resis-
tant (trypsin-stable pool) (Figure 3A). The trypsin-stable
pool of GM1 likely corresponds to the molecules inserted
into the plasma membrane, whereas the trypsin-labile pool
is probably composed of ganglioside interacting with pro-
teins protruding from the plasma membrane (Masserini et
al., 1990; Saqr et al., 1993). The trypsin-stable pool of GM1
was shown to be enriched in the fraction resistant to extrac-
tion with Triton X-100 at 4°C. After cells were incubated
with 100 mM tritiated GM1, 3.74 nmol GM1 (per milligram
protein) were found in the detergent-insoluble fraction,
whereas 1.26 nmol GM1 were recovered from the soluble
fraction, indicating that exogenous GM1 accumulates in
rafts.
To rule out that inhibition of cross-linking of GH-DAF is
due to the action of ganglioside loosely associated with the
surface, cross-linking was performed on GM1-loaded cells,
before and after incubation with BSA. The cross-linking
efficiency remained the same under the two conditions ([Fig-
ure 3B] variation of efficiency was ,5% for all conditions).
Hence, we conclude that gangliosides tightly associated
with the membrane are responsible for this inhibition of
cross-linking. Important was our finding that 70% of tightly
associated GM1 was incorporated into the bilayer by the
criterion used by previous authors (Kanda et al., 1982;
Schwarzmann et al., 1983). We cannot completely rule out
that the trypsin-labile pool contributes to inhibition of cross-
linking, but this must be a minor effect, especially because
the solubility of GH-DAF in TX-114 was significantly in-
creased by gangliosides (see below). This latter finding is
difficult to explain by ganglioside micelles bound to pro-
truding proteins.
Figure 2. Gangliosides inhibit cross-linking of FR-GPI in CHO
cells. CHO FR-GPI cells were incubated with 100 mM bbG or with
100 mM GM1 for 1 h at 37°C. Cells were subsequently subjected to
cross-linking with BS3. Proteins were resolved on 5–15% SDS-PAGE
and after Western blotting were detected with antifolate receptor
antibody followed by ECL.
Figure 3. Incorporation of GM1 into the plasma membrane of MDCK GH-DAF cells. (A) MDCK GH-DAF cells were incubated with 1
mCi/ml tritiated GM1 (final ganglioside concentration 100 mM) for 1 h at 37°C and subsequently washed with BSA for 0, 10, 20, 30, or 45 min
(open bars). The additive effect of trypsin treatment (0.1% trypsin for 5 min at 37°C) after washing with BSA is shown as solid bars for each
time point. (B) Cross-linking was performed after incubating GM1-loaded cells with BSA for 0, 10, 20, 30, or 45 min. SDS-PAGE, Western
blotting, and detection were as described in Figure 1.
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Gangliosides Change the Detergent Solubility of
GH-DAF
How do gangliosides inhibit cross-linking of GH-DAF? One
possibility is that GPI-APs are excluded from rafts by gan-
gliosides that are inserted into the lipid bilayer. An alterna-
tive explanation is that gangliosides bound to proteins pro-
truding from the surface of the plasma membrane affect
cross-linking by sterical hindrance. To distinguish between
these two possibilities another experimental strategy was
applied. An often used criterion for studying the association
of a protein with rafts is its resistance to extraction with
nonionic detergents such as Triton X-100 at 4°C (Brown and
Rose, 1992). This prompted us to investigate the detergent
solubility of GH-DAF after ganglioside loading of cells. We
found that solubility of GH-DAF in TX-114 was significantly
increased from 51 6 4 to 83 6 10 and 76 6 8% in GM1- and
bbG-loaded cells, respectively (Figure 4A).
It is known that depletion of cholesterol from cellular
membranes increases the solubility of GPI-APs in nonionic
detergent (Cerneus et al., 1993; Hanada et al., 1995; Scheiffele
et al., 1997). Confirming earlier reports, the solubility of
GH-DAF on TX-114 extraction was shifted to 80 6 7% after
extraction of membrane cholesterol with CD (Figure 4B). In
contrast, stabilization of rafts by antibody-induced cross-
linking decreases the solubility of GH-DAF to 34 6 7%
(Figure 4B).
These results indicate that manipulating the lipid content
of cellular membrane by application of exogenous ganglio-
sides modulates both the clustering behavior of GPI-APs
and the solubilization in TX-114 at 4°C. Taking together the
data from the chemical cross-linking and detergent-extrac-
tion approach, we suggest that gangliosides inserted into the
plasma membrane displace GPI-APs from lipid microdo-
mains.
Effect of Gangliosides on Rafts Is Not Due to
Solubilization of the Membrane
We have shown that loading of MDCK GH-DAF cells with
gangliosides displaces GPI-APs from rafts. To rule out the
possibility that these effects are partly due to detergent-like
properties of gangliosides, we used n-octyl-b-d-glucopyr-
anoside (OG). This detergent chemically resembles ganglio-
sides (i.e., containing carbohydrate head group) and is
known to fully solubilize GPI-APs when used above the
critical micellar concentration (20–25 mM). MDCK GH-DAF
cells were incubated with different concentrations of OG and
subjected to cross-linking with BS3. Using the same concen-
trations of OG as used for gangliosides (10–100 mM), no
effect on cross-linking of GH-DAF was observed. Even when
cells were incubated with a 100-fold higher concentration of
OG (10 mM), only a slight inhibition of cross-linking was
observed ([Figure 5] inhibition was 3.5 6 0.7%). Remarkably,
even under this condition membranes remained intact, be-
cause caveolin-1, a membrane protein having both N and C
termini exposed to cytoplasm, was not cross-linked. Caveo-
lin-1 was found as a high molecular weight cross-linked
product only when OG was applied above its critical micel-
lar concentration (20 mM). Treatment of MDCK GH-DAF
cells with 100 mM GM1 did not lead to cross-linking of
caveolin-1. Taken together, these data show that the inhibi-
tion of GH-DAF cross-linking by gangliosides is not due to
solubilization of the membrane by detergent-like properties
of gangliosides.
Figure 4. Gangliosides increase the detergent solubility of GH-
DAF. (A) MDCK GH-DAF cells were loaded with 100 mM bbG for
1 h at 37°C, with 100 mM NBD-C6-HPC for 1 h at 8°C, with 100 mM
GM1 for 1 h at 37°C, or with 100 mM bbG for 1 h followed by a 6-h
incubation period with serum containing DMEM (A) or treated with
10 mM methyl-b-cyclodextrin for 1 h at 37°C or incubated with
anti-GH for 1 h at 12°C followed by incubation with secondary
antibody (B). Cells were extracted with Triton X-114 for 30 min at
4°C and subjected to centrifugation, and GH-DAF in the soluble (S)
and insoluble fraction (I) was detected as described in MATERIALS
AND METHODS.
Figure 5. The effect of octylglucoside on rafts is different from that
of gangliosides. MDCK GH-DAF cells were incubated for 1 h with
5 and 10 mM octylglucoside and subjected to cross-linking with BS3.
A slight decrease of cross-linking was observed only with 10 mM
OG. For all concentrations tested, membranes remained intact (see
RESULTS).
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Inhibition of GH-DAF Cross-linking with
Gangliosides Is Specific and Reversible
We tested whether the clustering of GPI-anchored proteins
is a specific property of gangliosides. A lipid expected not to
be a constituent of rafts should have no effect on cross-
linking and solubility of GH-DAF. Optimally, phosphatidyl-
choline molecules such as those found in cell membranes
should be used for this control; however, these lipids cannot
be introduced into the membrane by exogenous addition.
We therefore used a partially water-soluble fluorescently
labeled analogue of phosphatidylcholine (NBD-C6-HPC). It
is known that NBD-C6-lipids are rapidly transferred to the
plasma membrane at low temperature, and their accumula-
tion in the plasma membrane is easily monitored by immu-
nofluorescence microscopy (Kok and Hoekstra, 1993). We
have tested the detergent insolubility of NBD-C6-HPC. Cells
were loaded with NBD-C6-HPC, and detergent extraction
was performed at 4°C with Triton X-114. More than 99% of
NBD-C6-HPC was recovered from the detergent-soluble
fraction, indicating that the lipid does not associate with
rafts. As expected, no change in the cross-linking pattern
was detected on incubation with various concentrations of
NBD-C6-HPC (cross-linking efficiency was 73 6 5% in cells
treated with 100 mM NBD-C6-HPC as compared with 73 6
6% in control cells) (Figure 6A). Also, solubility of GH-DAF
(54 6 2% soluble) was not changed by NBD-C6-HPC (Figure
4A).
To determine whether inhibition of GH-DAF cross-linking
by gangliosides is reversible, MDCK GH-DAF cells were
loaded with 100 mM bbG and subsequently incubated for 6 h
in serum-containing medium before cross-linking. As
shown in Figure 6B, 6 h of incubation with serum-containing
medium were sufficient to almost fully restore the cross-
linking pattern of GH-DAF (cross-linking efficiency was 6 6
1% lower than control cells).
The detergent insolubility of GH-DAF in TX-114 was also
restored by incubation of bbG-loaded cells with serum-con-
taining medium for 6 h (61 6 4% soluble) (Figure 4A).
Inhibition of Copatching of Influenza HA and GH-
DAF by Gangliosides
Rafts are thought to be small and highly dynamic structures,
which explains why they cannot be resolved by conven-
tional microscopical techniques. We wanted to test whether
loading of cells with gangliosides leads to a redistribution of
GPI-APs. The distribution of GH-DAF on MDCK cells with
or without bbG loading was analyzed by immunofluores-
cence labeling. To avoid postfixational redistribution of GH-
DAF we used formaldehyde fixation combined with subse-
quent methanol fixation (Harder et al., 1998). Incubation of
cells with 100 mM bbG for 1 h before fixation and antibody
labeling had no effect on the diffuse distribution of GH-DAF on
the cell surface (Figure 7, A and B). The intracellular staining is
derived from Golgi and/or endosomal localization of the pro-
Figure 6. The inhibition of cross-linking of GH-DAF is a specific
property of gangliosides. (A) MDCK GH-DAF cells were incubated
with 0, 10, 50, or 100 mM NBD-C6-HPC for 30 min at 8°C before
being subjected to cross-linking with BS3. SDS-PAGE, Western blot-
ting, and detection were as described in Figure 1. (B) MDCK GH-
DAF cells were incubated with 0 or 100 mM bbG for 1 h followed by
a 6-h incubation with serum-containing medium as indicated in the
figure. Cells were subjected to cross-linking followed by SDS-PAGE,
Western blotting, and detection as detailed in Figure 1.
Figure 7. Ganglioside treatment does not change the immunoflu-
orescence pattern of GH-DAF. MDCK GH-DAF cells were incu-
bated without any additions (A and D), with 100 mM bbG (B), and
with 10 mM CD (C) for 1 h at 37°C, respectively. Cells were fixed
and labeled with anti-GH antibody followed by Cy3-conjugated
anti-sheep IgG (A–C) or subjected to antibody-induced cross-link-
ing before fixation (D) as described in MATERIALS AND METH-
ODS.
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tein. Depletion of membrane cholesterol with 10 mM CD also
did not lead to detectable changes in the distribution of GH-
DAF (Figure 7C). In comparison, addition of antibodies to
GH-DAF before fixation led to a patched distribution of the
immunofluorescence signal (Figure 7D).
Recently, it was shown that incubating living cells simul-
taneously with antibodies against raft-associated proteins
leads to redistribution of the independently cross-linked
components into overlapping patches (Harder et al. 1998).
Copatching was only observed for pairs of raft markers but
not for pairs of raft/non-raft marker, suggesting attractive
forces in the common lipid environment of raft proteins
(Harder et al. 1998).
We used the same approach to investigate whether exoge-
nous application of gangliosides disturbs the physical connec-
tion of GH-DAF to lipid microdomains. As a raft-associated
protein marker we expressed the trimeric transmembrane pro-
tein influenza HA in MDCK GH-DAF cells.
Cells were incubated simultaneously with monoclonal
anti-HA and polyclonal anti-GH antibodies at 4°C, fol-
lowed by incubation with the respective secondary anti-
bodies. Microscopical analysis showed copatching of HA
and GH-DAF in the majority of cells (60% copatching, 35%
partial overlap, and 5% random distribution), confirming
the previous report by Harder et al. (1998) (Figure 8, A–F).
When cells were incubated for 1 h with 100 mM GM1
before antibody-induced cross-linking, in most cells only
partial coclustering of HA and GH-DAF was observed
(31% coclustering, 50% partial overlap, and 19% random
distribution) (Figure 8, G–L). This result shows that at-
tractive forces between patches of HA and GH-DAF are
disturbed by application of gangliosides and strengthens
Figure 8. Inhibition of copatching of influenza HA and GH-DAF by gangliosides. MDCK GH-DAF cells were infected with influenza HA
virus and then incubated with DMEM (A–F) or 100 mM GM1 in DMEM (G–L) for 1 h at 37°C. After subsequent treatment with a mixture of
monoclonal anti-HA and sheep polyclonal anti-GH antibodies at 4°C, patching was detected using Cy-3-anti-sheep–labeled (red) and
FITC-anti-mouse–labeled (green) secondary antibodies. Panels in the left column show distribution of GH, panels in the middle column show
distribution of HA, and panels in the right column show the merge of both signals. D–F display a detail of A–C correspondingly, whereas
J–L display that of G–I. Bars: F, L, 2 mm; C, I, 8 mm.
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our conclusion that GPI-APs are displaced from lipid
microdomains.
DISCUSSION
The aim of this study was to investigate how application of
gangliosides affects cholesterol–sphingolipid microdomains.
Previously, using a chemical cross-linking approach, we
have demonstrated that GPI-anchored proteins reside in
clusters on the surface of living cells (Friedrichson and Kur-
zchalia, 1998). Here we show that gangliosides inhibit cross-
linking of GPI-anchored proteins and moreover increase
their detergent solubility.
How do gangliosides exert these effects? The inhibitory
effect of gangliosides on cross-linking could be explained in
two ways. Firstly, because of the characteristic property of
sphingolipids (gangliosides) to self-aggregate, they could
enlarge existing rafts and therefore “dilute” GH-DAF mol-
ecules within them. The resulting increase of the distance
between neighboring GH-DAF molecules could then inter-
fere with cross-linking. Secondly, it is possible that applica-
tion of gangliosides displaces GPI-anchored proteins from
rafts by disrupting attractive forces between the GPI anchor
and surrounding lipids. The GPI-anchored proteins thereby
would be deprived of their lipid environment and could
escape from rafts. A similar destabilization or disassembly
of rafts would occur if gangliosides that do not associate
with GPI-AP–containing rafts sequester essential raft lipids,
such as cholesterol.
One way to distinguish between the possibilities raised
above is to analyze whether addition of exogenous ganglio-
sides leads to changes in the detergent solubility of GH-
DAF. It is known that GPI-anchored proteins are to a great
extent insoluble in nonionic detergents (Brown and Rose,
1992). A primary requirement for detergent insolubility in
vitro is the presence of optimal concentrations of cholesterol,
glycosphingolipids, and saturated acyl-chain–containing
phospholipids (Schroeder et al., 1998). Accordingly, deplet-
ing cells of cholesterol has been shown to increase detergent
solubility of GPI-APs (Cerneus et al., 1993; Hanada et al.,
1995); however, in the case of gangliosides the opposite is
true: loading cells with gangliosides renders GH-DAF de-
tergent soluble. This finding is somewhat unexpected, be-
cause increasing the concentration of a raft lipid would be
thought to result in raft stabilization. The fact that ganglio-
sides interfere with cross-linking and increase detergent sol-
ubility of GH-DAF suggests that they act in a raft-disrupting
manner, possibly driving GPI-APs partially out of rafts. This
view is supported by the finding that gangliosides disturb
the copatching of HA and GH-DAF. Copatching of two raft
components is most likely a consequence of the coalescence
of a common lipid microdomain.
What are the forces keeping rafts together? Lipid–lipid
interactions within rafts are poorly understood. Attractive
forces between the GPI-anchor and raft lipids have been
inferred from in vitro studies (Schroeder et al., 1994).
Interestingly, although GPI-anchored proteins are par-
tially insoluble in most nonionic detergents, octylglu-
coside completely solubilizes GPI-anchored proteins
(Brown and Rose, 1992). This detergent has a polar car-
bohydrate head group resembling naturally occurring
glycolipids that might be involved in disrupting the at-
tractive forces within sphingolipid– cholesterol rafts. The
finding of the lectin VIP36 in detergent-insoluble cell
extracts led to the proposal that carbohydrate interactions
are involved in raft recruitment of proteins (Fiedler et al.,
1994). We cross-linked GH-DAF in the presence of struc-
tural carbohydrates of the GPI-anchor, but no change in
the cross-linking pattern was detected (our unpublished
results). This finding does not support a role for carbohy-
drate interactions in raft assembly. Recently it was dem-
onstrated that rafts are stabilized by antibody-induced
cross-linking of a raft protein, which led to enhanced
resistance to Triton extraction (Harder et al., 1998).
The findings presented in this article might link effects
of exogenously added gangliosides on signaling path-
ways to raft function (Hakomori and Igarashi, 1995). GPI-
anchored proteins were reported to associate with ty-
rosine kinases of the src family (Brown, 1992). In addition,
caveolae, plasma membrane invaginations where cell sig-
naling proteins are concentrated, are involved in seques-
tering and organizing raft lipid domains. Many signal
transduction molecules, which are all modulated by gan-
gliosides, are found to be associated with sphingolipid–
cholesterol rafts or caveolae. PDGF, EGF, protein kinase
C, and the insulin receptor have been reported to localize
to caveolae (Liu et al., 1996; Couet et al., 1997; Liu et al.,
1997; Wu et al., 1997). At the same time, signal transduc-
tion pathways mediated by these molecules are inhibited
by the exogenous addition of gangliosides (Bremer et al.,
1984; Bremer et al., 1986; Hannun and Bell, 1987). There-
fore, agents causing clustering or unclustering of GPI-AP–
containing microdomains might be important tools for
modulating these signal transduction pathways. For ex-
ample, antibody-induced patching of GPI-anchored pla-
cental alkaline phosphatase leads to accumulation of the
src-like tyrosine kinase fyn (Harder et al., 1998). Physio-
logical responses induced by raft-clustering have been
described in lymphocytes (Brown, 1993). For example,
antibody-induced cross-linking of GPI-anchored proteins
leads to activation of T lymphocytes (Thomas and Samel-
son, 1992), and cross-linking of the IgE receptor FceRI
mediates an allergic response, including secretion of his-
tamine in mast cells (Holowka and Baird, 1996; Field et al.,
1997). Hence, many cellular signal-transduction events
might depend on the assembly of raft lipid and protein
components. Disassembly of rafts by exogenous applica-
tion of gangliosides could possibly antagonize raft-depen-
dent signal transduction. Tumor cells might exploit this
mechanism to escape immune response. It is well known
that gangliosides, which are shed by tumor cells, inhibit T
cell activation, which is a raft-mediated process (Lu and
Sharom, 1996; Lanzavecchia A. et al. 1999). Interestingly,
we detected an increase of autophosphorylation of several
protein kinases on addition of ganglioside to cells (our
unpublished observation).
In addition, gangliosides might be useful agents for
studying the pathogenesis of human diseases, which have
been linked to rafts. We have recently shown that choles-
terol depletion of hippocampal neurons inhibits secretion
of b-amyloid peptide, suggesting that rafts may play a
role in the proteolytic processing of the amyloid precursor
protein of Alzheimer’s disease (Simons et al., 1998). Trans-
formation of the GPI-anchored prion protein to the
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Scrapie protein isoform has also been associated with the
cholesterol–sphingolipid microdomains Taraboulos et al.,
1995). It will be interesting to see whether gangliosides
influence the processing of the amyloid precursor protein
or the prion protein.
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